LYMPHIR assigned permanent J-code J9161 by CMS, effective April 1, 2025

CITIUS ONCOLOGY, INC.

LYMPHIR (denileukin diftitox-cxdl) received permanent HCPCS J-code J9161 for IV use, 1 microgram.
J-code effective April 1, 2025, for claims submission by healthcare providers.
Code facilitates billing and reimbursement for commercial and government insurance (VA, DoD, Medicare).
Chairman Leonard Mazur states milestone supports patient access and coding clarity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.